The N-alkyl moiety of N-alkylated imino sugars is crucial for therapeutic activities of these compounds as inhibitors of glycosphingolipid (GSL) biosynthesis and as antivirals. The improved potency afforded by a long N-alkyl moiety is coincident with increased compound-induced cytotoxicity. Therefore, in the present study, we examined the mechanism of this cytotoxicity in detail. Despite N-butyl-deoxynojirimycin and N-butyl-deoxygalactonojirimycin inhibiting the glycosylation of ceramide to glucosylceramide, ceramide levels did not increase in HL60 cells treated with these compounds. Long-chain N-alkylated imino sugars were toxic to cells at concentrations considerably lower than the critical micellar concentrations for these compounds and ...
Abstract: The N-alkylated imino sugars have inhibitory activity against the first enzyme in the path...
Abnormalities in glycosphingolipid (GSL) biosynthesis have been implicated in the oncogenesis and ma...
Glycosphingolipid lysosomal storage diseases are a small but challenging group of human disorders to...
The N-alkyl moiety of N-alkylated imino sugars is crucial for therapeutic activities of these compou...
Deoxynojirimycin (DNJ) analogues are inhibitors of ceramide glucosyltransferase (CGT), which catalys...
Deoxynojirimycin (DNJ) analogues are inhibitors of ceramide glucosyltransferase (CGT), which catalys...
Ceramide glucosyltransferase (CGT) is a key enzyme in glycosphingolipid (GSL) biosynthesis in eukary...
The imino sugar N-butyldeoxynojirimycin (NB-DNJ) is a glucose analogue which inhibits the glycoprote...
Recently developed glucosylceramide synthase inhibitors with enhanced hydrophobicity display increas...
ABSTRACT. N-Butyldeoxynojirimycin (NB-DNJ) inhibits the ceramide glucosyltransferase which catalyses...
Glycosylation is the most common posttranslational modification of proteins. It is a complex process...
Many pathogenic microorganisms use host cell surface gly-coconjugates, including glycosphingolipids ...
We report that N-oleoylethanolamine (NOE), widely employed as a ceramidase inhibitor, also inhibits ...
The N-alkylated imino sugars have inhibitory activity against the first enzyme in the pathway for gl...
The imino sugar deoxynojirimycin and its alkylated derivatives are inhibitors of the N-linked oligos...
Abstract: The N-alkylated imino sugars have inhibitory activity against the first enzyme in the path...
Abnormalities in glycosphingolipid (GSL) biosynthesis have been implicated in the oncogenesis and ma...
Glycosphingolipid lysosomal storage diseases are a small but challenging group of human disorders to...
The N-alkyl moiety of N-alkylated imino sugars is crucial for therapeutic activities of these compou...
Deoxynojirimycin (DNJ) analogues are inhibitors of ceramide glucosyltransferase (CGT), which catalys...
Deoxynojirimycin (DNJ) analogues are inhibitors of ceramide glucosyltransferase (CGT), which catalys...
Ceramide glucosyltransferase (CGT) is a key enzyme in glycosphingolipid (GSL) biosynthesis in eukary...
The imino sugar N-butyldeoxynojirimycin (NB-DNJ) is a glucose analogue which inhibits the glycoprote...
Recently developed glucosylceramide synthase inhibitors with enhanced hydrophobicity display increas...
ABSTRACT. N-Butyldeoxynojirimycin (NB-DNJ) inhibits the ceramide glucosyltransferase which catalyses...
Glycosylation is the most common posttranslational modification of proteins. It is a complex process...
Many pathogenic microorganisms use host cell surface gly-coconjugates, including glycosphingolipids ...
We report that N-oleoylethanolamine (NOE), widely employed as a ceramidase inhibitor, also inhibits ...
The N-alkylated imino sugars have inhibitory activity against the first enzyme in the pathway for gl...
The imino sugar deoxynojirimycin and its alkylated derivatives are inhibitors of the N-linked oligos...
Abstract: The N-alkylated imino sugars have inhibitory activity against the first enzyme in the path...
Abnormalities in glycosphingolipid (GSL) biosynthesis have been implicated in the oncogenesis and ma...
Glycosphingolipid lysosomal storage diseases are a small but challenging group of human disorders to...